PREVENTION OF THE TRANSIENT ADVERSE-EFFECTS OF A GONADOTROPIN-RELEASING HORMONE ANALOG (BUSERELIN) IN METASTATIC PROSTATIC-CARCINOMA BY ADMINISTRATION OF AN ANTIANDROGEN (NILUTAMIDE)

被引：140

作者：

KUHN, JM

BILLEBAUD, T

NAVRATIL, H

MOULONGUET, A

FIET, J

GRISE, P

LOUIS, JF

COSTA, P

HUSSON, JM

DAHAN, R

BERTAGNA, C

EDELSTEIN, R

机构：

[1] HOP MONTFERMEIL, DEPT UROL, MONTFERMEIL, FRANCE

[2] INST ROUSSEL UCLAF, DEPT MED, ROMAINVILLE, FRANCE

[3] CHR NIMES, DEPT UROL, NIMES, FRANCE

[4] HOP BICHAT, DEPT UROL, F-75877 PARIS 18, FRANCE

[5] CHR ROUEN, DEPT ENDOCRINOL, ROUEN, FRANCE

[6] CHR ROUEN, DEPT UROL, ROUEN, FRANCE

[7] HOP ST LOUIS, BIOCHEM LAB, F-75475 PARIS 10, FRANCE

来源：

关键词：

D O I：

10.1056/NEJM198908173210701

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：413 / 418

页数：6

共 35 条

[1] PROSPECTIVE COMPARISON BETWEEN SERUM MONOCLONAL PROSTATE SPECIFIC ANTIGEN AND ACID-PHOSPHATASE MEASUREMENTS IN METASTATIC PROSTATIC-CANCER
AHMANN, FR
SCHIFMAN, RB
[J]. JOURNAL OF UROLOGY, 1987, 137 (03) : 431 - 434
[2] AHMED SR, 1983, LANCET, V2, P415
[3] ADVANCED-CARCINOMA OF THE PROSTATE - TREATMENT WITH A GONADOTROPIN-RELEASING HORMONE AGONIST
ALLEN, JM
OSHEA, JP
MASHITER, K
WILLIAMS, G
BLOOM, SR
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1983, 286 (6378): : 1607 - 1609
[4] AULITZKY W, 1987, J UROL S256A, V137
[5] BELAND G, 1988, HORMONAL THERAPY PRO, P302
[6] BOCCONGIBOD L, 1986, EUR UROL, V12, P400
[7] SUSTAINED SUPPRESSION OF TESTOSTERONE PRODUCTION BY THE LUTEINIZING-HORMONE RELEASING-HORMONE AGONIST BUSERELIN IN PATIENTS WITH ADVANCED PROSTATE CARCINOMA - A NEW THERAPEUTIC APPROACH
BORGMANN, V
HARDT, W
SCHMIDTGOLLWITZER, M
ADENAUER, H
NAGEL, R
[J]. LANCET, 1982, 1 (8281) : 1097 - 1099
[8] BOUFFIOUX C, 1986, Acta Urologica Belgica, V54, P304
[9] BRISSET JM, 1987, EORTC MONOGRAPH, V18, P17
[10] CRAWFORD ED, 1988, J UROL S339A, V139